Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1202 results about "Immunoassay" patented technology

An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes). The molecule detected by the immunoassay is often referred to as an "analyte" and is in many cases a protein, although it may be other kinds of molecules, of different size and types, as long as the proper antibodies that have the adequate properties for the assay are developed. Analytes in biological liquids such as serum or urine are frequently measured using immunoassays for medical and research purposes.

Bovine serum albumin combined nano antibody and application thereof

The invention discloses a bovine serum albumin combined nano antibody and a preparation method and application thereof, the amino acid sequence of the bovine serum albumin combined nano antibody Nb1 is shown as SEQ.ID No.1, the nano antibody Nb not only has high affinity to bovine serum albumin, but also has good binding activity to both human serum albumin and mouse serum albumin, and the nano antibody Nb has high affinity to human serum albumin and mouse serum albumin. And the antibody has a relatively good broad-spectrum application range, and can be widely applied to the aspects of drug half-life period enhancement, tumor targeted therapy and imaging, immunodetection or diagnosis, recombinant albumin purification or enrichment and the like.
Owner:SHANGHAI XINRUITE BIOMEDICAL TECH

Murine anti-PBP2a hybridoma cell strain, monoclonal antibody and application

The invention relates to a mouse anti-PBP2a hybridoma cell strain, a monoclonal antibody and application of the mouse anti-PBP2a hybridoma cell strain, staphylococcus aureus PBP2a protein is extracted as an antigen, after the high-purity antigen is obtained, a good immunoreaction is aroused in a mouse body, then a hybridoma technology is adopted, two cell strains with high affinity and specificity are screened, and the corresponding antibody is prepared; the two antibodies are used as a gold-labeled antibody and a coating antibody in a colloidal gold immunoassay kit, and the kit can be used for detecting PBP2a protein in methicillin-resistant staphylococcus aureus and can be used for developing related in-vitro diagnostic reagents.
Owner:TIANJIN ERA BIOLOGY TECH CO LTD +1

Anti-monkey C-reactive protein monoclonal antibody, enzyme-linked immunosorbent assay kit and its application

The present invention belongs to the field of biological detection technology, and specifically relates to an anti-monkey C-reactive protein monoclonal antibody, an enzyme-linked immunosorbent assay kit and its application. Named CRP-13, CRP-13 includes a heavy chain variable region and a light chain variable region; the heavy chain variable region has three complementary determining regions CDR-H1 to CDR-H3, and the amino acid sequences are shown in SEQ ID NO.6-SEQ ID NO.8; the light chain variable region has three complementary determining regions CDR-L1 to CDR-L3, and the amino acid sequences are shown in SEQ ID NO.9-SEQ ID NO.11. The monoclonal antibody of the present invention can specifically bind to monkey C-reactive protein with high specificity. The above monoclonal antibody can be used to screen a paired monoclonal antibody, and a monkey C-reactive protein enzyme-linked immunosorbent assay kit is obtained based on the combination of the monoclonal antibodies, which can detect the content of monkey C-reactive protein in monkey serum, plasma or tissue fluid.
Owner:WUHAN ELABSCIENCE BIOTECHNOLOGY CO LTD +1

Preparation of anti-p-Tau217 antibody and application of anti-p-Tau217 antibody in Alzheimer's disease detection kit

The invention provides preparation of an anti-p-Tau217 antibody and application of the anti-p-Tau217 antibody in an Alzheimer's disease detection kit, and belongs to the technical field of antibodies and immunodetection, the anti-p-Tau217 antibody comprises a heavy chain variable region and a light chain variable region, a coding gene of the heavy chain variable region comprises a nucleotide sequence shown in SEQ ID NO.1, and a coding gene of the light chain variable region comprises a nucleotide sequence shown in SEQ ID NO.2. The coding gene of the light chain variable region comprises a nucleotide sequence shown in SEQIDNO.3, the heavy chain variable region comprises an amino acid sequence shown in SEQIDNO.2, and the light chain variable region comprises an amino acid sequence shown in SEQIDNO.3. The invention also discloses a preparation method. The invention provides preparation of an anti-p-Tau217 antibody and application of the anti-p-Tau217 antibody in an Alzheimer's disease detection kit. The successful expression of the monoclonal anti-p-Tau217 antibody with high affinity is realized, and the monoclonal anti-p-Tau217 antibody is used for detecting the Alzheimer's disease.
Owner:SHANDONG LIFEI BIOLOGICAL IND CO LTD

Tumor detection data analysis method based on peripheral blood immune standard

The invention provides a tumor detection data analysis method based on a peripheral blood immune marker, and belongs to the technical field of immunodetection.The tumor detection data analysis method comprises the steps that firstly, a peripheral blood sample of a patient is collected, and plasma and cell components are separated; analyzing various immune cell phenotypes by using flow cytometry; determining the concentration of key cell factors; analyzing the molecular expression level of the immune checkpoint; establishing an immune cell subset proportion empirical function; analyzing a cell factor expression mode by using an immune lineage transcriptome analysis model; establishing a tumor immune microenvironment score by combining the immune cell subset proportion and a model output result; the accuracy of the scoring system is verified through clinical follow-up visit and iconography examination; a standardized report template is formulated to provide a tumor early detection basis. Wherein the immune lineage transcriptome analytical model adopts a multi-modal attention fusion network architecture, three different immune data streams can be processed and integrated at the same time, and accurate evaluation of tumor-related immune states is realized.
Owner:BAODING SECOND CENT HOSPITAL

Reagent blending processor for medical immunoassay

The invention relates to the related technical field of reagent mixing, and discloses a medical immunoassay reagent mixing processor which comprises a device body, a stepping motor is mounted on the upper side of the interior of the device body, a circular plate is fixedly arranged at the output end of the stepping motor, a disc is arranged on the upper side of the circular plate, and a plurality of placement grooves are formed in the interior of the disc in a circumferential array mode. An adjusting assembly is arranged in the middle of each containing groove. Centrifugal force generated by rotation of the disc is matched with inclined arrangement of the test tube, so that a reagent moves up and down along the inner wall of the test tube, and the reagent layered up and down in the test tube can be quickly and uniformly mixed up and down; the reagent in the test tube is prevented from being splashed through the sealing cover; under the guiding action of a convex block on an ejector rod and the elastic action of a hollow elastic piece, a plurality of sleeves and the test tube are shaken up and down, so that the efficiency of quickly and uniformly mixing the reagents which are layered up and down in the test tube is improved.
Owner:HANGZHOU LINAN DISTRICT FIRST PEOPLES HOSPITAL (MEDICAL COMMUNITY OF HANGZHOU LINAN DISTRICT FIRST PEOPLES HOSPITAL)

Targeted giant salamander iridovirus nano antibody as well as preparation method and application thereof

The invention provides a targeted giant salamander iridovirus nano antibody as well as a preparation method and application thereof. The invention discloses a giant salamander iridovirus targeting nano antibody, and aims to provide a giant salamander iridovirus targeting nano antibody which is low in expression cost, low in difficulty and stable in source, can be effectively combined with giant salamander iridovirus, and specifically realizes immunoassay of the giant salamander iridovirus. The amino acid sequences of the nano antibody are shown as SEQ ID NO.1-6, and the nano antibody belongs to the technical field of biological science.
Owner:ZHEJIANG UNIV

Cat serum albumin combined nano antibody and application thereof

The invention discloses a cat serum albumin combined nano antibody as well as a preparation method and application thereof, and relates to the technical field of nano antibody engineering. Wherein the amino acid sequence of the cat serum albumin binding nano antibody Nb1 is shown as SEQ.ID NO.1, and the nano antibody Nb1 not only has higher affinity to cat serum albumin, but also has better binding activity to mouse serum albumin; the polypeptide can be widely applied to the aspects of drug half-life period enhancement, tumor targeted therapy and imaging, immunodetection or diagnosis, recombinant albumin purification or enrichment and the like in the pet treatment process.
Owner:SHANGHAI XINRUITE BIOMEDICAL TECH

Rabbit monoclonal antibody mAb6 of anti-mouse immunoglobulin G2a subtype (IgG2a) and application thereof

The invention belongs to the technical field of immunodetection, and discloses a rabbit monoclonal antibody mAb6 of an anti-mouse immune globulin G2a subtype (IgG2a) and application thereof. The rabbit monoclonal antibody mAb6 comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1-3, the LCDR1 comprises an amino acid sequence KSVYKNNY, the LCDR2 comprises an amino acid sequence GTN, and the LCDR3 comprises an amino acid sequence AGGYID; the heavy chain variable region comprises HCDR1-3, the HCDR1 comprises an amino acid sequence RFSLSNYR, the HCDR2 comprises an amino acid sequence IFTRGST, and the HCDR3 comprises an amino acid sequence ARGWNS. The rabbit monoclonal antibody disclosed by the invention can be combined with a mouse immune globulin G2a subtype (IgG2a) in a high-specificity manner, can be applied to immunodetection, and provides a basis for further preparation of engineering antibodies.
Owner:ORIGENE WUXI BIOTECHNOLOGY CO LTD

Anti-T3 antibody mAb32 or antigen binding fragment, preparation method and application

The invention belongs to the technical field of immunodetection, and discloses an anti-T3 antibody mAb32 or an antigen binding fragment, the anti-T3 antibody mAb32 or the antigen binding fragment comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3, the amino acid sequence of the LCDR1 is shown as SEQ ID NO.1, the amino acid sequence of the LCDR2 is IAS, and the amino acid sequence of the LCDR3 is shown as SEQ ID NO.3; the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3, and the amino acid sequences of the HCDR1, the HCDR2 and the HCDR3 are respectively shown as SEQ ID NO. 4-6. When the anti-T3 antibody mAb32 is used for detecting a T3 standard antigen, the detection sensitivity is lower than 0.2 ng / ml, and when a clinical sample is detected through a magnetochemiluminescence method, the correlation with R clinical comparison is good within the sample range of 1-80 pmol / L.
Owner:ORIGENE WUXI BIOTECHNOLOGY CO LTD

Anti-human inflammatory factor interleukin 6 monoclonal antibody and application thereof

The invention discloses an anti-human inflammatory factor interleukin 6 monoclonal antibody and an application thereof. When the monoclonal antibody is prepared, an adopted immunogen is a human inflammatory factor interleukin 6 antigen, and an amino acid sequence of the human inflammatory factor interleukin 6 antigen comprises a sequence as shown in SEQ ID NO: 1. A group of monoclonal antibodies specifically combined with antigens is constructed based on the IL-6 antigens. The IL-6 monoclonal antibody has strong binding capacity with an IL-6 antigen in a clinical sample, has no cross reaction with other proteins, has good specificity and affinity compared with a commercial antigen, can be effectively applied to ELISA and a dry-type immunofluorescence method, has good detection linearity, precision, stability and accuracy, and can be widely applied to the field of immunoassay. The antibody can be combined with the antigen to serve as a detection reagent raw material combination, and has clinical detection advantages.
Owner:SHENZHEN INSTITUTE FOR DRUG CONTROL (SHENZHEN TESTING CENTER OF MEDICAL DEVICES) +1

Methods and related aspects for performing label-free single-molecule immunoassays

Provided herein are methods of detecting target molecules. The methods include contacting a sample comprising the target molecule with a substrate that comprises a plurality of capture antibodies, or antigen binding portions thereof, that specifically bind to the target molecule to form captured target molecules, and contacting the captured target molecules with a plurality of detection antibodies, or antigen binding portions thereof, that bind to the captured target molecules to form target molecule complexes. The methods also include taking images of the target molecule complexes to produce imaged target molecule complexes, and quantifying an amount of target molecules in the sample using the imaged target molecule complexes. Additional methods as well as related devices and systems are also provided.
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA

Fully automated single-molecule immunoassay analyzer

PCT designated stage expiredWO2025139746A1Material analysisImmune profilingElectric machinery
A fully automated single‑molecule immunoassay analyzer, comprising a sample adding module (1), a reagent module (4), an incubation temperature control module (7), and an optical detection module. The incubation temperature control module (7) comprises: a turntable (85) provided with multiple circumferentially arranged bearing positions (86) for reaction vessels (57); a motor (81) and a first rotating shaft (82), the turntable (85) being fixed on the first rotating shaft (82), and the motor (81) driving the first rotating shaft (82) to rotate; a heating component and a temperature sensor disposed on the turntable (85); an enclosure (84) and an upper cover (87), the enclosure (84) surrounding the turntable (85), and the upper cover (87) being disposed at an upper opening of the enclosure (84); and a mixing mechanism (5) disposed below the turntable (85), wherein when the turntable (85) rotates and a reaction vessel (57) at any of the bearing positions (86) is above the mixing mechanism (5), the mixing mechanism (5) lifts the reaction vessel (57) and rotates.
Owner:HANGZHOU GETOTEC CO LTD

Preparation of heterojunction dual-photoelectrode type photoelectrochemical sensor based on multi-ball cascade DNA reaction amplification

The invention belongs to the technical field of immunoassay and biosensing, and provides a novel construction mode of a heterojunction dual-photoelectrode photoelectric sensing strategy and a preparation method of an in-situ heterojunction MIO photocathode. The invention relates to a preparation method of a heterojunction dual-photoelectrode type photoelectrochemical sensor based on multi-ball cascade DNA reaction amplification. Specifically, the design is composed of an In2O3 / CdS photoanode and an in-situ formed MIL-68 / In2O3 (MIO) photocathode. The heterojunction dual-photoelectrode sensing strategy effectively prolongs an electron-hole transmission path, enhances photo-generated charge separation, and realizes' super-open 'PEC signal output, thereby providing a steady baseline for signal conversion. Meanwhile, a multi-sphere cascade DNA reaction is combined to output a three-dimensional DNA net structure to provide a large number of sites for embedding of a PEC quenching probe doxorubicin-ferrocene carboxylic acid (DOX-FcCOOH), obvious PEC signal quenching is realized by utilizing the efficient competitive electron transfer capability of the three-dimensional DNA net structure, and finally, a signal conversion system with'opening-super opening-closing 'multistage response characteristics is constructed. The detection of the nucleic acid marker Pax-5a gene of the B cell acute lymphatic leukemia is realized by detecting target objects with different concentrations.
Owner:SHANDONG UNIV OF TECH

Antibody or antigen binding fragment thereof as well as related products and application thereof

The invention discloses an antibody or an antigen binding fragment thereof and a related product and application thereof, and relates to the field of immunodetection, the antibody comprises HCDR1, HCDR2 and HCDR3 in a heavy chain variable region of which the amino acid sequence is shown as SEQ ID NO: 28 and LCDR1, LCDR2 and LCDR3 in a light chain variable region of which the amino acid sequence is shown as SEQ ID NO: 29, the antibody can be specifically combined with HPV18 type E6-E7 fusion protein, and the antibody can be used for detecting the HPV18 type E6-E7 fusion protein. The method has the advantages of high detection sensitivity, good specificity, high accuracy, good repeatability and the like, and provides a way for effective detection of the HPV18 type E6-E7 fusion protein.
Owner:CHENGDU HUARENKANG BIOTECHNOLOGY CO LTD

Homogeneous assay

Among other things, the present invention is related to devices and methods of performing biological and chemical assays, such as but not limited to immunoassays and nucleic assay acid, particularly the homogeneous assay that does not use the step of wash and that is fast (e.g. 60 seconds from dropping a sample to displaying results).
Owner:ESSENLIX CORP

Anti-T3 antibody mAb68 or antigen binding fragment, preparation method and application

The invention belongs to the technical field of immunodetection, and discloses an anti-T3 antibody mAb68 or an antigen binding fragment, the anti-T3 antibody mAb68 or the antigen binding fragment comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3, the amino acid sequence of the LCDR1 is shown as SEQ ID NO.1, the amino acid sequence of the LCDR2 is TAS, and the amino acid sequence of the LCDR3 is shown as SEQ ID NO.3; the heavy variable region comprises HCDR1, HCDR2 and HCDR3, and the amino acid sequences of the HCDR1, the HCDR2 and the HCDR3 are respectively shown as SEQ ID NO. 4-6. When the anti-T3 antibody mAb68 is used for detecting a T3 standard antigen, the detection sensitivity is lower than 0.2 ng / ml, a clinical sample is detected through a magnetochemiluminescence method, and the correlation with R clinical comparison is good within the sample range of 1-80 pmol / L.
Owner:ORIGENE WUXI BIOTECHNOLOGY CO LTD

Preparation method and application of antibiotic electrochemical luminescence sensor with double enhancement strategies

The invention belongs to the technical field of immunoassay and biosensing detection, and particularly relates to a preparation method and application of an antibiotic electrochemical luminescence sensor based on a double-enhancement strategy. According to the invention, a bifunctional metal organic gel is used as a substrate, a graphite-phase carbon nitride quantum dot is used as a luminous body, and a self-assembly split aptamer walker is combined to construct the electrochemical luminescence sensor for sensitive detection of antibiotics. The sensor has the advantages of extremely high specificity and sensitivity, wide detection range, low detection limit and strong anti-interference performance, and has important scientific significance and application value in detection of antibiotic residues in the environment.
Owner:SHANDONG UNIV OF TECH

Serum amyloid protein A determination kit and preparation and application thereof

The invention provides a serum amyloid A determination kit as well as preparation and application thereof, the kit optimizes and screens components and concentrations of buffer systems and inorganic salts in a reagent 1 and a reagent 2, particularly adds polyanions and DSS, and uses a quenching agent in the preparation process of anti-SAA antibody coated latex particles. According to the kit prepared by optimizing and screening the components, the specific recognition and binding capacity to the serum amyloid protein A is remarkably improved, the performance indexes such as the sensitivity, the linear range, the anti-interference capacity, the stability and the repeatability of the kit are improved, the linearity of a detection value in the linear range of 2mg / L to 500mg / L is good, the detection value is accurate and usable, and the kit is suitable for being used in the field of detection of the serum amyloid protein A. Therefore, the comprehensive performance of immunoassay on the serum amyloid protein A is improved.
Owner:BEIJING WANTEDERUI DIAGNOSTIC TECH CO LTD

Full-automatic single-molecule fluorescence immunoassay analyzer

The invention relates to the technical field of immunoassay, in particular to a full-automatic single-molecule fluorescence immunoassay analyzer which comprises an analyzer body and a sample adding bin and further comprises a plurality of transfer pipes located in the sample adding bin. The knocking rods are located in the sample adding bin, the knocking rods are used for knocking and vibrating the bottom of the transfer pipe, when the full-automatic single-molecule fluorescence immunoassay analyzer is used, the existence of bubbles can interfere with reading of fluorescence signals, so that an analysis result is inaccurate, the bubbles are discharged through knocking and vibrating, and the accuracy of the analysis result is improved. According to the method, accurate reading of fluorescence signals can be ensured, so that the analysis accuracy is improved, the fluorescence signal intensity is optimized, bubbles can shield part of the fluorescence signals, the signal intensity is weakened, after the bubbles are discharged, the fluorescence signals can be more fully detected, the signal intensity is optimized, and the result is clearer.
Owner:YOUDA BIOTECHNOLOGY (SHIJIAZHUANG) CO LTD

Hybridoma cell strain capable of secreting anti-napropamide monoclonal antibody and application of hybridoma cell strain

The invention relates to a hybridoma cell strain capable of secreting a napropamide-resistant monoclonal antibody and application of the hybridoma cell strain, and belongs to the field of food safety immunodetection. The hybridoma cell strain Tau4 secreting the napropamide cloned antibody is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation date is October 31, 2024, and the preservation number is CGMCC No.46242. The hybridoma cell strain Tau4 secreting the napropamide cloned antibody has the advantages that the hybridoma cell strain Tau4 secreting the napropamide The napropamide-resistant monoclonal antibody secreted by the cell strain is used for analyzing and detecting napropamide residues in food safety detection. The napropamide-resistant monoclonal antibody cell strain obtained by the invention can be used for immunoassay detection, and has better detection sensitivity and specificity (IC50 value is 1.13 ng / mL) on napropamide. The result of the invention can be used for preparing an immunodetection kit and a colloidal gold test strip of napropamide, and provides a powerful detection method and means for detecting the residual quantity of napropamide in foods such as fruits, vegetables and the like.
Owner:JIANGNAN UNIV

HIV GP41 variants for immunodiagnostic assays

The present invention relates to novel HIV gp41 antigen compositions suitable for the detection of antibodies against HIV in isolated biological samples, thereby providing highly specific immunoassay results. The invention further relates to a method for detecting an HIV antibody, to the use of the novel HIV gp41 antigen composition in an immunoassay, and to a kit comprising the novel HIV gp41 antigen composition.
Owner:F HOFFMANN LA ROCHE & CO AG

Computer-implemented method for detecting analytes in immunoassays

Computer-implemented systems and methods for detecting one or more analytes in an immunoassay are provided. Embodiments systems and methods of the present disclosure may train a machine learning network using immunoassay reference data regarding an analyte and output a set of target experimental input parameters to detect the analyte. The machine learning network may utilize the received data to generate a target parameter, and may develop an immunoassay parameter set to detect and / or quantify an object. The computer-implemented systems and methods of the present disclosure may also generate a troubleshooting assistance output for immunoassays.
Owner:INVITROGEN BIOSERVICES INDIA PTE LTD

Hybridoma cell strain secreting mefos monoclonal antibody and application of hybridoma cell strain

The invention relates to a hybridoma cell strain capable of secreting a mefos monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of immunodetection. According to the invention, the hybridoma cell strain capable of secreting the fenofos monoclonal antibody is obtained through screening, the fenofos monoclonal antibody has high specificity and high sensitivity to the fenofos, IC50 to the fenofos is 0.231 ng / mL, and the fenofos monoclonal antibody has no cross reaction to structural analogues of the fenofos, such as triazophos, diazinon, phorate, acetyl phorate, methamidophos and the like; therefore, low-concentration isoprophos can be accurately detected.
Owner:JIANGNAN UNIV

Biotin ligase mutant, coding gene thereof, expression vector, recombinant cell and application of biotin ligase mutant

The invention belongs to the technical field of gene engineering, and particularly relates to a biotin ligase mutant as well as a coding gene, an expression vector, a recombinant cell and application thereof. The amino acid sequence of the biotin ligase mutant is as shown in SEQ ID NO. 2. The biotin ligase (Bar A) mutant provided by the invention can be efficiently expressed in eukaryotes, the expression level of the biotin ligase (Bar A) mutant is obviously improved in mammalian cells compared with a wild type, and the biotin ligase (Bar A) mutant has good catalytic activity after expression, can effectively catalyze biotinylation of protein containing a biotin receptor sequence, and has good application prospects. The method has a wide application prospect in the fields of biotinylated protein preparation, and protein labeling, positioning, immunodetection, affinity purification, function research and the like based on a biotin-avidin system (BAS).
Owner:YOURUISAISI (WUHAN) BIOTECHNOLOGY CO LTD

Quality control liquid and application thereof

The invention provides a quality control solution and application thereof, the quality control solution comprises a buffer solution, a polymer, EDTA (Ethylene Diamine Tetraacetic Acid) or a salt thereof, a preservative, a blood simulation dye and an analyte, and the polymer is selected from PEG (Polyethylene Glycol) 2000-6000, propylene glycol, glycerol or a combination thereof. The quality control liquid provided by the invention can be used for quality control of at least one analyte; the kit does not need refrigeration, freezing or freeze-drying, can be placed at room temperature, is convenient to use, and can be used in the fields of immunodetection, biochemical detection and electrochemical detection.
Owner:ACON BIOTECH (HANGZHOU) CO LTD

Extracellular vesicle biomarker for diagnosing non-small cell lung cancer and application of extracellular vesicle biomarker

The invention provides protein biomarkers for diagnosing non-small cell lung cancer based on proteins MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4 and APOD which are obtained in vitro from plasma extracellular vesicles of a patient and are used as the protein biomarkers for diagnosing the non-small cell lung cancer. The biomarkers have the advantages of high sensitivity and high specificity, and have important scientific research and clinical application values. According to the biomarker provided by the invention, the non-small cell lung cancer can be subjected to early-stage diagnosis without biopsy sampling of pulmonary nodule tissues or imaging examination, the pain of a patient is small, detection can be carried out through a protein immunoassay technology or a proteomics technology, and the detection efficiency is high; therefore, the auxiliary diagnostic kit convenient for clinical application can provide laboratory support for screening, diagnosis and treatment of the non-small cell lung cancer. Data information obtained through the omics technology is integrated with clinical information, so that the pathological process of the non-small cell lung cancer can be better known, a new intervention target spot is found, and clinical management of a patient is improved.
Owner:INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES

Hybridoma cell strain secreting dextromethorphan monoclonal antibody and application thereof

The invention relates to a hybridoma cell strain capable of secreting dextromethorphan monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of immunodetection. The monoclonal antibody secreted by the hybridoma cell strain disclosed by the invention has good sensitivity and specificity on dextromethorphan, wherein the IC50 value on the dextromethorphan is 0.162 ng / mL. The monoclonal antibody provided by the invention has no cross reaction on structural analogues of dextromethorphan, such as fentanyl, thilazine, papaverine, morphine and medetomidine, and has good specificity, so that the dextromethorphan with low concentration can be accurately detected.
Owner:JIANGNAN UNIV

ANA detection image-text report intelligent generation method and system

The invention discloses an ANA detection image-text report intelligent generation method and system, and relates to the technical field of immunodetection, the system uses different fluorescent markers to mark ANA, signal sensitivity is enhanced, and detection accuracy is ensured. Then, collecting fluorescence signals of different wavelengths by adopting a fluorescence microscope and a multi-wavelength excitation light source, and obtaining dynamic change data of reaction intensity by combining a time-resolved fluorescence imaging technology to generate a multi-channel imaging data set; thirdly, noise removal, signal enhancement and image alignment are carried out through an image preprocessing technology, and data consistency is ensured; based on a multi-channel data set, a convolutional neural network is used for training and testing an initial model, an intelligent detection model is constructed, a fluorescence reaction mode is extracted, finally, a detailed ANA detection report is automatically generated by calculating a comprehensive scoring coefficient and comparing the comprehensive scoring coefficient with a preset threshold value, and an accurate immunodiagnosis basis is provided for doctors.
Owner:GUANGZHOU HUISHAN MEDICAL TECH CO LTD +1